Table 3.
Treatment benefit group (N=115) | Procedure‐averse group (N=25) | P value | |
---|---|---|---|
Age, y, mean (SD) | 64 (16) | 63 (16) | 0.66 |
Male sex, n (%) | 62 (54) | 10 (40) | 0.19 |
Estimated glomerular filtration rate, mean (SD), mL/min 1.73 m2 | 39 (27) | 29 (20) | 0.09 |
Duration of chronic kidney disease, mean (median), y | 9 (6) | 9 (6) | 0.97 |
Prior invasive procedure, n (%) | 29 (25) | 10 (40) | 0.14 |
Prior heart attack, n (%) | 14 (13) | 5 (22) | 0.25 |
Prior stroke, n (%) | 7 (6) | 3 (14) | 0.23 |
History of acute kidney injury, n (%) | 10 (10) | 2 (9) | 0.83 |
Prior dialysis treatment, n (%) | 4 (4) | 1 (4) | 0.90 |
Received dialysis modality education, n (%) | 23 (21) | 9 (38) | 0.08 |
Have made a dialysis treatment choice, n (%) | 63 (55) | 15 (60) | 0.63 |
Goals of care designation,* n (%) | |||
Includes resuscitation | 53 (71) | 8 (47) | |
No resuscitation | 22 (29) | 9 (53) | 0.06 |
Based on 92 respondents.